NCT07081750

Brief Summary

This interventional study aims to evaluate the efficacy of a dyadic personalized home-based activity program in managing behavioral and psychological symptoms of dementia (BPSD) among home-dwelling people living with mild-to-moderate dementia post-discharge. The main question it aims to answer is: Does the dyadic personalized home-based activity program significantly reduce BPSD in individuals post-discharge with mild-to-moderate dementia? Researchers will compare individuals living with mild to moderate dementia who are receiving routine care to see if the dyadic personalized home-based activity program is effective for BPSD. Participants will:

  1. 1.In-hospital stage: A personalized home-based activity intervention plan is tailored for patients. Family caregivers receive professional training on care skills related to home-based activities and are provided with corresponding activity resources and support.
  2. 2.Post-discharge home-based stage: The intervention is delivered by family caregivers for a total of 12 weeks. The intervention is recommended to be performed twice per week, with each session lasting about 30 minutes in accordance with the patient's individual tolerance. Intermittent rest is advised (e.g., a 2-3 minute break every 10 minutes). The weekly intervention frequency and session duration can be flexibly adjusted according to the family caregivers' schedule and the patient's condition, including mood fluctuations and physical discomfort. Family caregivers are required to record the patient's activity participation, subjective feelings and behavioral responses, and submit regular feedback to the research team. Based on feedback from patients and family caregivers, the research team will conduct dynamic adjustments and continuous optimization of the intervention program throughout the study.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 6, 2025

Completed
14 days until next milestone

Study Start

First participant enrolled

July 20, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 23, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Completed
Last Updated

May 11, 2026

Status Verified

May 1, 2026

Enrollment Period

12 months

First QC Date

July 6, 2025

Last Update Submit

May 6, 2026

Conditions

Keywords

dementiabehavioral and psychological symptomshome-basedactivity

Outcome Measures

Primary Outcomes (2)

  • Behavioral and Psychological Symptoms of Dementia

    Assessment using the Neuropsychiatric Inventory (NPI) yields scores ranging from 0 to 144, with higher scores indicating more severe neuropsychiatric symptoms

    Baseline and post-intervention (at the end of week 12)

  • Caregiver Distress of Behavioral and Psychological Symptoms of Dementia

    Assessment using the caregiver distress section of the Neuropsychiatric Inventory (NPI) yields scores ranging from 0 to 60, with higher scores indicating greater caregiver distress levels

    Baseline and post-intervention (at the end of week 12)

Secondary Outcomes (16)

  • Cognitive Function of Dementia Patients

    Baseline and post-intervention (at the end of week 12)

  • Activities of Daily Living of Dementia Patients

    Baseline and post-intervention (at the end of week 12)

  • Apathy of Dementia Patients

    Baseline and post-intervention (at the end of week 12)

  • Agitation of Dementia Patients

    Baseline and post-intervention (at the end of week 12)

  • Quality of Life in Dementia

    Baseline and post-intervention (at the end of week 12)

  • +11 more secondary outcomes

Other Outcomes (3)

  • Number of caregivers with varying levels of satisfaction towards the intervention

    Post-intervention (at the end of week 12)

  • Number of dementia patients with varying levels of satisfaction towards the intervention

    Post-intervention (at the end of week 12)

  • Number of completed activity intervention sessions for dementia patients

    Post-intervention (at the end of week 12)

Study Arms (2)

Dyadic personalized home-based activity program intervention

EXPERIMENTAL

1. In - hospital stage: A personalized home - based activity intervention program is tailored for patients. Family caregivers receive training on care skills related to home - based activities and are provided with corresponding activity resources and support. 2. Post-discharge home-based stage: The intervention is delivered by family caregivers for a total of 12 weeks.

Behavioral: Dyadic personalized home-based activity program intervention

Routine care

OTHER

Participants will receive routine care consisting of standard hospitalization treatment, basic caregiver education on behavioral and psychological symptoms of dementia (BPSD), routine discharge instructions (including general home activity recommendations without personalized intervention assessment, planning or implementation), and routine post-discharge follow-up for 12 weeks.

Other: Routine care

Interventions

1. In - hospital stage: A personalized home - based activity intervention program is tailored for patients. Family caregivers receive training on care skills related to home - based activities and are provided with corresponding activity resources and support. 2. Post-discharge home-based stage: The intervention is delivered by family caregivers for a total of 12 weeks.

Dyadic personalized home-based activity program intervention

Participants will receive routine care consisting of standard hospitalization treatment, basic caregiver education on behavioral and psychological symptoms of dementia (BPSD), routine discharge instructions (including general home activity recommendations without personalized intervention assessment, planning or implementation), and routine post-discharge follow-up for 12 weeks.

Routine care

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be aged ≥ 60 years;
  • Have a diagnosis of dementia according to ICD-10 criteria, with a Clinical Dementia Rating (CDR) score of 1-2 (mild-to-moderate stage);
  • Retain basic verbal communication ability;
  • Present at least one neuropsychiatric symptom (a score ≥ 1 on any single item) within the past month, as evaluated by the Neuropsychiatric Inventory (NPI);
  • Be medically fit for hospital discharge and scheduled to receive home care post-discharge;
  • Be willing to participate in this study and provide written informed consent.
  • Family Caregivers
  • Be aged ≥ 18 years;
  • Have kinship with the patient (e.g., spouse, children, siblings, etc.);
  • Undertake primary care responsibilities on an unpaid, non-professional basis, and have the longest average daily care hours among all family caregivers;
  • Be willing to assume continuous home care responsibilities for at least 3 months post-discharge;
  • Have intact verbal communication skills;
  • Possess basic proficiency in operating the WeChat application (a widely used social communication application in China), including independently sending and receiving messages, as well as making voice and video calls;
  • Be willing to participate in this study and provide written informed consent.

You may not qualify if:

  • Have severe somatic diseases (e.g., malignant tumors, heart failure, physical disabilities) or severe psychiatric disorders;
  • Have severe visual or hearing impairment;
  • Have dementia secondary to the following conditions: central nervous system diseases (e.g., encephalitis, brain tumors, epilepsy, multiple sclerosis, Parkinson's disease), nutritional and metabolic disorders (e.g., thyroid dysfunction, vitamin B12 or folate deficiency), substance or alcohol dependence, and other potential causes of secondary dementia;
  • Suffer from severe physical or mental disorders, extreme debilitation, long-term bedridden status, end-stage disease with a life expectancy of less than six months, or be unable to cooperate with or tolerate the study intervention;
  • Be enrolled in any other clinical research that may interfere with the outcomes of this study.
  • Family Caregivers
  • Have severe somatic diseases (e.g., malignant tumors, heart failure, physical disabilities) or severe psychiatric disorders;
  • Have severe visual or hearing impairment;
  • Be enrolled in any other clinical research that may interfere with the outcomes of this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Union Hospital Affiliated to Fujian Medical University

Fujian, Fuzhou, China

RECRUITING

MeSH Terms

Conditions

DementiaBehaviorMotor Activity

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental Disorders

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Graduate Researcher

Study Record Dates

First Submitted

July 6, 2025

First Posted

July 23, 2025

Study Start

July 20, 2025

Primary Completion

June 30, 2026

Study Completion

June 30, 2026

Last Updated

May 11, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

Locations